Iwicki Mark T
Inhibikase Therapeutics, Inc. · Chief Executive Officer
Iwicki Mark T is listed in public filings as director, officer: Chief Executive Officer. This Iwicki Mark T insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Inhibikase Therapeutics, Inc. (IKT), Merus N.V. (MRUS), Akero Therapeutics, Inc. (AKRO), Q32 Bio Inc. (QTTB), and Third Harmonic Bio, Inc. (THRD). Investors use Iwicki Mark T's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Current Price | |
|---|---|---|---|---|---|
| $10M5M shares | Grant / ExerciseJan 5, 2026 | $10.0M5M shares | $2.01 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $073.6k shares | OtherDec 12, 2025 | $7.1M73.6k shares | $97.00 | -- | |
| $013.2k shares | OtherDec 12, 2025 | $548.8K13.2k shares | $41.60 | -- | |
| $08.8k shares | OtherDec 12, 2025 | $431.0K8.8k shares | $48.73 | -- | |
| $014.4k shares | OtherDec 12, 2025 | $335.7K14.4k shares | $23.29 | -- | |
| $016.6k shares | OtherDec 12, 2025 | $308.2K16.6k shares | $18.56 | -- | |
| $08.6k shares | OtherDec 12, 2025 | $138.9K8.6k shares | $16.09 | -- | |
| $06.1k shares | OtherDec 12, 2025 | $129.4K6.1k shares | $21.15 | -- | |
| $05k shares | OtherDec 12, 2025 | $116.1K5k shares | $23.30 | -- | |
| $08.5k shares | OtherDec 12, 2025 | $113.5K8.5k shares | $13.35 | -- | |
| $05.7k shares | OtherDec 12, 2025 | $108.0K5.7k shares | $19.12 | -- | |
| $015k shares | OtherDec 9, 2025 | $762.5K15k shares | $50.83 | -- | |
| $026k shares | OtherDec 9, 2025 | $598.5K26k shares | $23.02 | -- | |
| $070.6k shares | OtherDec 9, 2025 | $494.7K70.6k shares | $7.01 | -- | |
| $013k shares | OtherDec 9, 2025 | $342.2K13k shares | $26.32 | -- | |
| $013k shares | OtherDec 9, 2025 | $327.6K13k shares | $25.20 | -- | |
| --9.4k shares | OtherDec 9, 2025 | Disclosure amount unavailable9.4k shares | -- | -- | |
| $015k shares | OtherDec 9, 2025 | $122.0K15k shares | $8.13 | -- | |
| $011.5k shares | OtherDec 9, 2025 | $73.1K11.5k shares | $6.36 | -- | |
| $076.2k shares | OtherDec 9, 2025 | $46.9K76.2k shares | $0.615 | -- | |
| $150k53.5k shares | Grant / ExerciseOct 23, 2025 | $149.9K53.5k shares | $2.80 | -- | |
| $0128.6k shares | OtherAug 11, 2025 | $688.2K128.6k shares | $5.35 | -- | |
| --83.3k shares | OtherAug 11, 2025 | Disclosure amount unavailable83.3k shares | -- | -- | |
| --9.4k shares | Grant / ExerciseJun 3, 2025 | Disclosure amount unavailable9.4k shares | -- | -- | |
| $549k13.2k shares | Grant / ExerciseMay 22, 2025 | $548.8K13.2k shares | $41.60 | -- | |
| $025.5k shares | OtherFeb 24, 2025 | $429.5K25.5k shares | $16.82 | -- | |
| $95k37.2k shares | Grant / ExerciseFeb 24, 2025 | $94.5K37.2k shares | $2.54 | -- | |
| $65k25.5k shares | Grant / ExerciseFeb 24, 2025 | $64.9K25.5k shares | $2.54 | -- | |
| $07.6k shares | OtherFeb 24, 2025 | $55.5K7.6k shares | $7.29 | -- | |
| $19k7.6k shares | Grant / ExerciseFeb 24, 2025 | $19.3K7.6k shares | $2.54 | -- | |
| $1.8M602.3k shares | Grant / ExerciseFeb 21, 2025 | $1.8M602.3k shares | $2.97 | -- | |
| $1.3M602.3k shares | Grant / ExerciseFeb 21, 2025 | $1.3M602.3k shares | $2.23 | -- | |
| $4.2M1.8M shares | Grant / ExerciseFeb 17, 2025 | $4.2M1.8M shares | $2.35 | -- | |
| $10M4.4M shares | Grant / ExerciseFeb 14, 2025 | $10.3M4.4M shares | $2.35 | -- |